UNSPSC 51451908: Oxyclozanide or zanil

This classification denotes an antihelminthic agent with the molecular formula C13H6Cl5NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1QS9G4876X, chemically known as 3,5,6,3,5-pentachloro-2,2-dihydroxybenzanilide but generally known as oxyclozanide, which bears US NIH Compound Identifier 16779. European Medicines Agency schedules Oxyclozanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09561MIG. The term OXYCLOZANIDE is an International Non-Proprietary Name.

OXYCLOZANIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Oxyclozanide or zanil bears US NLM identifiers UMLS ID C0030046 and NCI Concept Code C66279. SMILES: C1=C(C=C(C(=C1CL)O)NC(=O)C2=C(C(=CC(=C2CL)CL)CL)O)CL.

UNSPSC 51451908 Oxyclozanide or zanil is a Commodity code that does not align with recent state and local procurement activity. The recent opportunities posted under this code—naloxone and drug deactivation systems (Seminole County, Florida), therapeutic pharmacy initiative direct-to-manufacturer prescriptions (Texas Health and Human Services Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products (Minnesota Multistate Cooperative Purchasing Alliance)—address broad pharmaceutical procurement, emergency medical supplies, and pharmacy benefit management rather than the specific antiparasitic compound named in the code taxonomy. The divergence between the code's nominal scope and actual buying activity suggests either a cataloging mismatch in the state and local procurement systems or that the code is being used as a catch-all for pharmaceutical and medical supply categories it does not precisely describe.

Recent activity spans state health agencies, county health departments, municipal fire services, and multistate cooperative purchasing vehicles across Florida, Texas, Minnesota, and Oregon. Seminole County's IFB posted June 30, 2026 seeks 1,900 units of naloxone and 800 drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa's IFB 26P00145 posted March 25, 2026 for medical and first aid supplies to support the Fire Department Rescue Division, with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside; and the Minnesota Multistate Cooperative Purchasing Alliance issued an RFP on January 20, 2026 for generic pharmaceuticals and over-the-counter products with a March 26, 2026 proposal deadline and July 1, 2026 contract effective date. The mismatch between the code name and the work being bought under it warrants clarification before pursuing opportunities tagged to this code.